Register for SOSV Climate Tech Summit – Nov 3-7, 2025 (Virtual, Free). Learn More

Improving the diagnosis and treatment of cancers

Team

Sam Frishman

Founder, CEO

MDC

Company details

At MDC, we’re revolutionizing diagnosis and treatment of soft tissue cancer with a novel robotic system that provides physicians direct access inside imaging scanners. Our technology enables physicians to perform interventions with live MRI guidance, leading to unprecedented accuracy and efficiency. We’re creating a new era of minimally invasive surgery, and our initial device will improve outcomes of biopsies and ablations at reduced costs.

Get In Touch with MDC

Please tell us a little bit about yourself and why you'd like to get connected. MDC + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More